Results 261 to 270 of about 195,645 (350)

Epstein–Barr virus and wild p53 in idiopathic pulmonary fibrosis

, 2001
She Lok, James P. Stewart, B. Kelly, P S Hasleton, J. Egan   +4 more
openalex   +1 more source

Glutamine Metabolism: Molecular Regulation, Biological Functions, and Diseases

MedComm, Volume 6, Issue 7, July 2025.
Tumor cells adapt to nutrient‐poor environments by altering metabolism to acquire essential nutrients. They convert glutamine into glutamate and α‐ketoglutarate, supporting mTOR activation and sugar biosynthesis. Disruption of mTORC1 signaling is linked to disease, while glutamine and leucine activation promotes cell growth and inhibits autophagy ...
Mudasir A. Kumar, Sana Khurshid Baba, Inamu Rashid Khan, Mohd Shahnawaz Khan, Fohad Mabood Husain, Saheem Ahmad, Mohammad Haris, Mayank Singh, Ammira S. Al‐Shabeeb Akil, Muzafar A. Macha, Ajaz A. Bhat   +10 more
wiley   +1 more source

Insight into the efficacy and safety of pirfenidone: The treatment of idiopathic pulmonary fibrosis. [PDF]

World J Clin Cases
Xu LY, Yu Y, Cen LS.
europepmc   +1 more source

Autoimmune Diseases: Molecular Pathogenesis and Therapeutic Targets

MedComm, Volume 6, Issue 7, July 2025.
This review provides a comprehensive overview of common autoimmune diseases, details clinical manifestations and summarizes the pathogenesis, including the breakdown of immune tolerance, initiation of autoimmune responses, and their progressive amplification.
Xiaoshuang Song, Hantian Liang, Fang Nan, Wenjing Chen, Junyao Li, Liu He, Yiping Cun, Zhenhong Li, Wei Zhang, Dunfang Zhang   +9 more
wiley   +1 more source

ITGAV, a specific biomarker associated with the pathogenesis of idiopathic pulmonary fibrosis. [PDF]

Sci Rep
Bi Z, Wang X, Liu X, Zhu X, Zang G, Tian L, Zhang W.   +6 more
europepmc   +1 more source

Aberrant Wnt/β-Catenin Pathway Activation in Idiopathic Pulmonary Fibrosis [PDF]

, 2003
Marco Chilosi, Venerino Poletti, Alberto Zamò, Maurizio Lestani, Licia Montagna, P Piccoli, Serena Pedron, Manuela Bertaso, Aldo Scarpa, Bruno Murer, Alessandra Cancellieri, Roberta Maestro, Gianpietro Semenzato, Claudio Doglioni   +13 more
openalex   +1 more source

Outpatient Intravenous Dobutamine as Right Ventricular Support During Inhaled Prostacyclin Uptitration in Severe PH‐ILD

Pulmonary Circulation, Volume 15, Issue 3, July 2025.
ABSTRACT PH‐ILD carries a poor prognosis, particularly with PVR > 5 WU. The INCREASE trial demonstrated the successful use of inhaled treprostinil, but slow uptitration delays the effects. Our study suggests outpatient IV dobutamine as interim support, improving contractility and reducing PVR during uptitration.
A. Kumar, Siddharth V. Ramanan, Brett Carollo, Kristen Swanson, Raj Parikh   +4 more
wiley   +1 more source

Advances in idiopathic pulmonary fibrosis diagnosis and treatment. [PDF]

Chin Med J Pulm Crit Care Med
Liu H, Shen J, He C.
europepmc   +1 more source

Epidemiology of Idiopathic Pulmonary Fibrosis [PDF]

, 2003

openalex   +1 more source

Practical Considerations for Managing Patients on Tyvaso DPI (Treprostinil Inhalation Powder)

Pulmonary Circulation, Volume 15, Issue 3, July 2025.
ABSTRACT Pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH‐ILD) require a multifaceted, guideline‐directed management approach. This includes active patient participation in partnership with their healthcare team to minimize disease impact and improve survival.
Jennifer H. Keeley, Jacqueline Skarre, Lori Reed, Loida A. Johnson, Catherine Falardeau, Brittany N. J. Davis, Manisit Das, Howard Castillo, Susanne McDevitt   +8 more
wiley   +1 more source